Trial intelligence / Profile preview

Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis

NCT07152860Not yet recruiting

Start
Dec 2025
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised, open-label trial in chronic atrophic gastritis (CAG) (2 arms). Primary endpoint: Total pathological response rate at 24 weeks. Planned start Dec 2025; status: not yet recruiting.

02

Conditions

chronic atrophic gastritis (CAG)

Beyond the preview

Go deeper on NCT07152860.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07152860.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call